News and Opinions

Results of a phase I clinical trial released in STEM CELLS Translational Medicine shows there is a strong possibility that stem cells may alleviate lymphedema, a chronic debilitating condition affecting up to one in three women treated for breast cancer. Durham, NC –...

—Assistant physician and Missouri state legislator indicted for wire fraud, other crimes by Kristina Fiore, Director of Enterprise & Investigative Reporting,  MedPage Today February 4, 2021 - A Missouri state lawmaker and medical professional was indicted by a...

JANUARY 19, 2021 —UTSA has launched a collaborative research institute that will benefit people suffering from a variety of vascular and other medical issues. The lnstitute of Regenerative Medicine will provide a unique resource and collection of research and...

Durham, NC – Karīna Narbute, Ph.D. is the latest recipient of STEM CELLS Translational Medicine’s Young Investigator Award. The award fosters advancements in the field of stem cells and regenerative medicine by honoring a young researcher who is the principal author...

International Society for Stem Cell Research Retinal cells derived from adult human eye stem cells survived when transplanted into the eyes of monkeys, an important early step in the validation of this approach for treating blindness, according to a study by Liu, et...

Durham, NC – Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise in treating angiitis-induced critical limb ischemia were released today in STEM CELLS...

Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...

Melbourne, Australia; December 18, and New York, USA; December 17, 2020: Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today provided an update on the randomized controlled trial of remestemcel-L in ventilator-dependent patients with moderate to severe acute respiratory...

On December 7th, a Dragon spacecraft loaded with thousands of pounds of critical supplies and research docked with the International Space Station (ISS), paving the way for an incredibly busy Expedition 64 dedicated to executing science on the orbiting laboratory....

Durham, NC - Intraventricular hemorrhage (IVH) - or bleeding in the brain - is a devastating condition common to premature babies, especially those born more than 10 weeks early. Injuries to the brain induced by severe IVH and the ensuing pressure caused by fluid...

WINSTON-SALEM, NC, Dec., 2020 -- The Wake Forest Institute for Regenerative Medicine (WFIRM) and the Regenerative Medicine Foundation (RMF) have announced that the 16th World Stem Cell Summit will be held in conjunction with the 7th annual Regenerative Medicine...

The award will recognize foreign-born scientists that immigrated to the US and whose work has made a profound contribution to the field of stem cell biology. WASHINGTON,D.C., UNITED STATES, December 10, 2020 /EINPresswire.com/ -- The Regenerative Medicine Foundation...

by NC Biotech Center — November 27, 2020 . Three academic scientists at two North Carolina universities are among the recipients of the first seed grants from the Amnion Foundation for research projects that will study cells derived from birth tissue to better...

December 2, 2020 / Yimy Villa Evie Junior is participating in a CIRM funded clinical trial for sickle cell disease that uses a stem cell gene therapy approach. Image credit: UCLA Broad Stem Cell Research Center For Evie Junior, personal health and fitness have always...

November 27, 2019 - By Susan Buckles Early research published in Mayo Clinic Proceedings examines the first case at Mayo Clinic of stem cell therapy tested in humans for spinal cord injury. The case study found stem cell intervention, which took place after standard...

Melbourne, Australia; December 2 and New York; USA; December 1, 2020: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States Food and Drug Administration (FDA) has...

Durham, NC – A new treatment for atherosclerosis, commonly known as hardening of the arteries, may be on the horizon, according to a study released today in STEM CELLS Translational Medicine (SCTM). The study demonstrates how injecting mice with early outgrowth cells...

The Passage of Proposition 14 Underscores Californians’ Commitment to Continue Investments in the Discovery of Groundbreaking Treatments and Cures for Chronic Diseases and Conditions   PALO ALTO, CA – The YES on Proposition 14 campaign today announced that a majority...